Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tie2 regulates endocardial sprouting and myocardial trabeculation
Xianghu Qu, … , Cristina Harmelink, H. Scott Baldwin
Xianghu Qu, … , Cristina Harmelink, H. Scott Baldwin
Published May 21, 2019
Citation Information: JCI Insight. 2019;4(13):e96002. https://doi.org/10.1172/jci.insight.96002.
View: Text | PDF
Research Article Cardiology Development

Tie2 regulates endocardial sprouting and myocardial trabeculation

  • Text
  • PDF
Abstract

The ang1-tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie2) pathway is required for normal vascular development, but its molecular effectors are not well-defined during cardiac ontogeny. Here, we show that endocardial-specific attenuation of Tie2 results in midgestation lethality due to heart defects associated with a hyperplastic but simplified trabecular meshwork (fewer but thicker trabeculae). Reduced proliferation and production of endocardial cells following endocardial loss of Tie2 results in decreased endocardial sprouting required for trabecular assembly and extension. The hyperplastic trabeculae result from enhanced proliferation of trabecular cardiomyocytes, which is associated with upregulation of bone morphogenetic protein 10, increased retinoic acid (RA) signaling, and extracellular signal-regulated protein kinases 1 and 2 hyperphosphorylation in the myocardium. Intriguingly, myocardial phenotypes in conditional knockout hearts could be partially rescued by inhibiting in utero RA signaling with pan-RA receptor antagonist BMS493. These findings reveal 2 complementary functions of endocardial Tie2 during ventricular chamber formation: ensuring normal trabeculation by supporting endocardial cell proliferation and sprouting and preventing hypertrabeculation via suppression of RA signaling in trabecular cardiomyocytes.

Authors

Xianghu Qu, Cristina Harmelink, H. Scott Baldwin

×

Figure 5

Endocardial attenuation of Tie2 results in decreased Notch signaling.

Options: View larger image (or click on image) Download as PowerPoint
Endocardial attenuation of Tie2 results in decreased Notch signaling.
(A...
(A) qPCR analysis of genes associated with Notch signaling pathway detected reduced expression of Notch1 and Dll1 in E11.5 Tie2-cko hearts, although there was no significant change in expression of other components or downstream targets. (B) Quantification of N1ICD/endomucin double-immunostained hearts revealed that N1ICD+ ECs in Tie2-cko left ventricles were significantly reduced at E10.5, E11.5, and E12.0 when compared with the controls. (C–F) Dual immunostaining of control and Tie2-cko heart sections at E11.5 for NICD1 (red) and endomucin (green). In comparison with the control, the reduction of N1ICD staining in the mutant endocardium is more significant at the base of the forming trabeculae (arrows) than in distal endocardium (arrowheads). Scale bars: 50 μm. A representative of more than 10 images was chosen for each panel; n = 3 (A) or 5 (B) per group. *P < 0.05; **P < 0.01, Student’s t test (A) and 2-way ANOVA (B).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts